InsiderClue
Stocks · Health care · Pharmaceutical Preparations

ProMIS Neurosciences Inc.

PMN Clue Score53
Ontario, Canada Fiscal year ends December CIK 0001374339
$9.61 +5.03% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $9.61 +6,764.29% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
Operating incomeNet income
Fiscal year 2021Operating income−8.3Net income−9.8EPS, diluted−1.69Fiscal year 2022Operating income−23.4Net income−18.1EPS, diluted−2.41Fiscal year 2023Operating income−14.3Net income−13.2EPS, diluted−1.07Fiscal year 2024Operating income−16.8Net income2.8EPS, diluted2.63Fiscal year 2025Operating income−40.2Net income−39.7 −1,529.3%EPS, diluted−22.61
FY2021FY2022FY2023FY2024FY2025
Operating income −8.3 −23.4 −14.3 −16.8 −40.2
Net income −9.8 −18.1 −13.2 2.8 −39.7
Growth −1,529.3%
EPS, diluted −1.69 −2.41 −1.07 2.63 −22.61

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2021Operating cash flow−9.3Capital expenditure−0.0Free cash flow−9.3Fiscal year 2022Operating cash flow−17.0Capital expenditure−0.0Free cash flow−17.0Fiscal year 2023Operating cash flow−10.8Fiscal year 2024Operating cash flow−27.2Fiscal year 2025Operating cash flow−28.1
FY2021FY2022FY2023FY2024FY2025
Operating cash flow −9.3 −17.0 −10.8 −27.2 −28.1
Capital expenditure −0.0 −0.0 n/a n/a n/a
Free cash flow −9.3 −17.0 n/a n/a n/a
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2021Cash16.9Total debt3.9Net cash (debt)13.0Shareholders’ equity5.7Debt to equity0.69Fiscal year 2022Cash5.9Shareholders’ equity−1.3Fiscal year 2023Cash12.6Total debt0.0Net cash (debt)12.6Shareholders’ equity3.8Debt to equity0.00Fiscal year 2024Cash13.3Shareholders’ equity16.5Fiscal year 2025Cash6.1Shareholders’ equity−1.3
FY2021FY2022FY2023FY2024FY2025
Cash 16.9 5.9 12.6 13.3 6.1
Total debt 3.9 n/a 0.0 n/a n/a
Net cash (debt) 13.0 n/a 12.6 n/a n/a
Shareholders’ equity 5.7 −1.3 3.8 16.5 −1.3
Debt to equity 0.69 n/a 0.00 n/a n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Ratios

Percentages worked out from the filed figures; debt to equity in times. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Returns
−173.0% n/a −352.0% 16.9% n/a
−55.2% −260.8% −97.0% 14.7% −432.6%
Balance and payout
0.69 n/a 0.00 n/a n/a
68.1% 119.5% 72.4% 12.8% 113.7%